Episode Details

Back to Episodes
Treating the Untreatable in Rheumatoid Arthritis! Rob Armstrong, CEO, Artax Biopharma

Treating the Untreatable in Rheumatoid Arthritis! Rob Armstrong, CEO, Artax Biopharma

Episode 25040 Published 1 year ago
Description

40% of all rheumatoid arthritis patients do not respond to any of the current drugs. Rob Armstrong, CEO of Artax Biopharma, aims to bring new hope for those patients who've been left without effective treatment options.

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us